You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Title |
ErbB2+ metastatic breast cancer treatment after progression on trastuzumab: a cost-effectiveness analysis for a developing country.
|
---|---|
Published in |
Revista de Salud Pública, May 2014
|
DOI | 10.15446/rsap.v16n2.31690 |
Pubmed ID | |
Authors |
Mario García Molina, Liliana Alejandra Chicaíza-Becerra, Liliana Alejandra Chicaíza-Becerra, Carlos Castañeda, Carlos Castañeda, Oscar Gamboa Garay, Oscar Gamboa Garay |
Mendeley readers
The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 95 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 20 | 21% |
Student > Master | 15 | 16% |
Other | 7 | 7% |
Student > Bachelor | 6 | 6% |
Lecturer | 6 | 6% |
Other | 16 | 17% |
Unknown | 25 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 27 | 28% |
Pharmacology, Toxicology and Pharmaceutical Science | 10 | 11% |
Economics, Econometrics and Finance | 10 | 11% |
Social Sciences | 4 | 4% |
Nursing and Health Professions | 2 | 2% |
Other | 8 | 8% |
Unknown | 34 | 36% |